BEIJING MESOCHEM TECHNOLOGY CO LTD

Overview

BEIJING MESOCHEM TECHNOLOGY CO LTD is an active pharmaceutical ingredient (API) supplier with 5 active FDA Type II Drug Master Files, covering EMPAGLIFLOZN; FRESH NK CELL ACTIVATION AND EXPANSION KIT; MESENCHYMAL STEM CELL SERUM-FREE MEDIUM (WITH SUPPLEMENTS); TOFACITINIB CITRATE; VONOPRAZAN FUMARATE.

API / Drug Master Files

BEIJING MESOCHEM TECHNOLOGY CO LTD holds 5 active (5 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• MESENCHYMAL STEM CELL SERUM-FREE MEDIUM (WITH SUPPLEMENTS)Active2025-07-25
• FRESH NK CELL ACTIVATION AND EXPANSION KITActive2025-07-25
• EMPAGLIFLOZNActive2018-11-07
• VONOPRAZAN FUMARATEActive2018-06-26
• TOFACITINIB CITRATEActive2018-01-22

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to BEIJING MESOCHEM TECHNOLOGY CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.